2020-11-13T13:55:55-06:00 2019-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2019-01-01 541379174 ALLIANCE FOR AGING RESEARCH ALLI 2022932856 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 SUSAN PESCHIN PRESIDENT AND CEO 2022932856 2020-11-05 1 PATRICIA DROLET P00362984 3019860600 2020-11-05 2019 2022-09-23 18:48:47Z SUSAN PESCHIN 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 3034932 0 X WWW.AGINGRESEARCH.ORG X 1986 DC PROMOTE RESEARCH TO ENHANCE THE EXPERIENCE OF AGING AND HEALTH. 17 17 13 1 0 0 2568722 2767169 0 0 95302 78842 -54280 -100043 2609744 2745968 92826 0 0 0 1335009 1246648 0 0 91002 1479810 1314601 2907645 2561249 -297901 184719 3012438 3419554 307590 309210 2704848 3110344 X THE ALLIANCE FOR AGING RESEARCH IS THE LEADING NON-PROFIT ORGANIZATION DEDICATED TO ACCELERATING THE PACE OF SCIENTIFIC DISCOVERIES AND THEIR APPLICATION IN ORDER TO VASTLY IMPROVE THE UNIVERSAL HUMAN EXPERIENCE OF AGING AND HEALTH. 0 0 2168622 EVERY HEARTBEAT MATTERSNATIONAL HEART VALVE DISEASE AWARENESS DAYTHE ALLIANCE LED THE THIRD-ANNUAL NATIONAL HEART VALVE DISEASEAWARENESS DAY ON FEBRUARY 22ND, 2019. WE WERE JOINED BY 64 NATIONALORGANIZATIONS DEDICATED TO RAISING AWARENESS ABOUT THIS SERIOUSDISEASE. ON VALVE DISEASE DAY AND THROUGHOUT THE MONTH, PARTNERSACROSS THE COUNTRY HOSTED MORE THAN 30 IN-PERSON AND ON-LINEEDUCATIONAL EVENTS. A FLAGSHIP EVENT AT MEDSTAR HEART & VASCULARINSTITUTE-ATTENDED BY >100 CLINICIANS AND VIEWED BY >2,500 ON FACEBOOKLIVE-FEATURED DR. JOHN WHYTE, MD OF WEBMD, AND U.S. SURGEON GENERALVICE ADMIRAL JEROME ADAMS, MD, MPH. PARTNER EFFORTS AND A MARKETINGCAMPAIGN REACHED >154 MILLION ESTIMATED AUDIENCE, AND >8.5 MILLION PAN FOUNDATIONIN PARTNERSHIP WITH THE PAN FOUNDATION, THE ALLIANCE CONVENED TWO ROUNDTABLES OF STAKEHOLDERS INTERESTED IN LOWERING OOP COSTS AND PROVIDING A SMOOTHING OPTION FOR MEDICARE BENEFICIARIES WITH PART D COVERAGE. ATTENDEES INCLUDED SENIOR CONGRESSIONAL COMMITTEE STAFF, AHIP, PCMA, PHRMA, BIO, BMA, AND 20 NATIONAL ADVOCACY ORGANIZATIONS REPRESENTING THINK TANKS, PHARMACIES, PROVIDERS, PATIENTS, AND FAMILY CAREGIVERS. AS A RESULT OF THIS MEETING, ORGANIZED A SIGN-ON CONSENSUS LETTER IN SUPPORT OF A PART D OOP CAP AND SMOOTHING THAT WAS SENT TO SENATE FINANCE COMMITTEE AND HOUSE COMMITTEE ON WAYS & MEANS, AS WELL AS SENATE AND HOUSE LEADERSHIP. ADDITIONALLY, THE ALLIANCE AND MORNING CONSULT CONDUCTED A QUANTITATIVE NATIONAL SURVEY ON OOP COSTS AMONG OLDER ADULTS OVER AGE 65 WHO HAVE MEDICARE PART D COVERAGE, INCLUDING THOSE WHO LIVE WITH ONE OR MORE CHRONIC CONDITIONS, AND "PRE-SENIOR" ADULTS AGED 60-64. THE SURVEY RESULTS WERE FEATURED IN AN OP-ED CO-AUTHORED BY THE ALLIANCE AND NATIONAL HEALTH COUNCIL, "SENIORS STRUGGLE WITH OUT-OF-POCKET DRUG COSTS. A CAP WOULD FIX THIS, AND PUBLISHED IN MORNING CONSULT. ACCELERATING CURE/TREATMENTS FOR ALZHEIMER'S DISEASE COALITION (ACT-AD). THE ALLIANCE LEADS AN ALZHEIMER'S DISEASE COALITION WITH INDUSTRY EXPERTS AND STAKEHOLDERS. ACT-AD HELD ITS 12TH ANNUAL FDA/ALZHEIMER'S DISEASE ALLIES MEETING ENTITLED "DIVERSIFYING THE THERAPEUTIC PIPELINE FOR ALZHEIMER'S DISEASE" WITH DRUG SPONSORS, PATIENT ADVOCACY ORGANIZATIONS, AND REPRESENTATIVES FROM THE NATIONAL INSTITUTES OF HEALTH AND U.S. FOOD AND DRUG ADMINISTRATION. THE COALITION ALSO HELD AN EDUCATIONAL WEBINAR ON CLINICAL TRIAL RECRUITMENT ISSUES IN ALZHEIMER'S DISEASE WITH FEDERAL ALZHEIMER'S DISEASE RESEARCHERS AND INDUSTRY. 2168622 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 24 0 13 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 17 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X X X SUSAN PESCHIN CEO 2022932856 1700 K ST NW NO 740 WASHINGTON DC 20006 JAMES G SCOTT CHAIR 3.00 X X 0 0 0 JOHN L STEFFENS CHAIR EMERITUS 3.00 X 0 0 0 BRUCE GARREN VICE CHAIR 3.00 X 0 0 0 WILLIAM SCHUYLER TREASURER 3.00 X X 0 0 0 GEORGE BEACH SECRETARY 3.00 X X 0 0 0 JOHN ALAM BOARD MEMBER 1.00 X 0 0 0 KAREN GALLY BOARD MEMBER 1.00 X 0 0 0 JOHN BREAUX BOARD MEMBER 1.00 X 0 0 0 KELSEY LANG BOARD MEMBER 1.00 X 0 0 0 MARGARET DAVIS-CERONE BOARD MEMBER 1.00 X 0 0 0 JAMES E EDEN BOARD MEMBER 1.00 X 0 0 0 BARRY LIDEN BOARD MEMBER 1.00 X 0 0 0 MICHELE MARKUS BOARD MEMBER 1.00 X 0 0 0 DAN PERRY FOUNDER & BOARD MEMBER 1.00 X 0 0 0 CALVIN SCHMIDT BOARD MEMBER 1.00 X 0 0 0 MARK SIMON BOARD MEMBER 1.00 X 0 0 0 BILLY TAUZIN BOARD MEMBER 1.00 X 0 0 0 SUSAN PESCHIN PRESIDENT AND CEO 40.00 X 190761 0 15061 YVETTE BROWN VP OF FINANCE AND ADMINIST 40.00 X 130130 0 15969 LINDSAY CLARKE VP OF HEALTH PROGRAMS 40.00 X 117915 0 17442 ELLEN JENKINS VP PUBLIC POLICY 40.00 X 143781 0 11193 LAUREN SMITH EMPLOYEE 40.00 X 107353 0 15833 689940 0 75498 5 0 1 0 BERMAN AND COMPANY 1090 VERMONT AVE NW SUITE 800 WASHINGTON DC 20005 RESTRICTED PROJECT WORK AND WEBSITE MANA 234034 DRINKER BIDDLE & REATH LLP 1 LOGAN SQUARE 2000 PHILADELPHIA PA 19103 PUBLIC POLICY CONSULTING SERVICES 138696 1700 K STREET ASSOCIATES 1700 K ST NW WASHINGTON DC 20006 RENTAL OF OFFICE SPACE 122635 3 422698 2344471 2767169 54910 54910 169507 145575 23932 23932 23932 41875 422698 143389 -101514 -101514 HONORARIA 900099 1200 1200 PUBLICATIONS 900099 271 271 1471 2745968 0 0 -21201 X 765438 540893 189568 34977 347896 246145 86267 15484 44429 31038 10878 2513 88885 60630 20840 7415 39329 39329 420536 390391 12258 17887 214171 198173 15994 4 31285 23638 7556 91 94980 37852 48192 8936 182346 182346 37196 29714 5940 1542 116637 108805 6896 936 1075 1075 31678 31678 6823 6823 DONATIONS & PASSTHROUGH 103009 101082 1845 82 OTHER EXPENSES 16451 1046 14676 729 DUES AND SUBSCRIPTIONS 15717 537 14896 284 BANK FEES 3368 4 3242 122 398674 -398674 2561249 2168622 301625 91002 365188 346622 110430 104303 381500 534000 70 419 19697 29742 254205 138520 135363 115685 1985335 2273928 14855 14855 3012438 3419554 221046 170862 86544 138348 307590 309210 X 1845803 2329835 859045 780509 2704848 3110344 3012438 3419554 184719 220777 0 X X 0 1 X 1 0 X 2144755 1000564 1950657 2568722 2761169 10425867 2144755 1000564 1950657 2568722 2761169 10425867 10425867 22232 23282 63078 44159 54910 207661 2400 510 999 2006 1471 7386 10640914 0.97980 0.98010 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 16613 16613 2544636 2561249 278062 69516 0 0 206515 278496 295382 278062 1058455 1587683 6149 7229 5502 16613 35493 51629 69624 73846 69516 264615 396923 510928 510928 510928 510928 510928 4412 4412 510928 22147 5431 16716 232058 133089 98969 115685 DEFERRED RENT 129312 CAPITAL LEASE PAYABLE 9036 138348 X 6154394 220777 3044260 143389 3408426 2745968 0 2745968 5748898 3044260 143389 3187649 2561249 0 2561249 PART X, LINE 2: THE ALLIANCE FOR AGING RESEARCH(AAR) REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. AAR DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. AAR'S FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, REMAIN OPEN FOR EXAMINATION BY THE FEDERAL TAXING AUTHORITIES GENERALLY FOR THREE YEARS AFTER FILING. PART XI, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES: 143,389 PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES: 143,389 ANNUAL DINNER/ROUNDTABLE EVENT 464573 422698 41875 25664 45003 72722 464573 422698 41875 25664 45003 72722 143389 -101514 X X X X 0 0 0 0 0 0 0 0 0 SUSAN PESCHIN PRESIDENT AND CEO 190761 0 0 0 0 0 294 0 14767 0 205822 0 0 0 ELLEN JENKINS VP PUBLIC POLICY 143781 0 0 0 0 0 0 0 11193 0 154974 0 0 0 FORM 990, PART VI, SECTION A, LINE 1 THE BOARD MAY APPOINT AN EXECUTIVE COMMITTEE AND MAY DELEGATE TO THAT COMMITTEE ALL OF THE POWERS OF THE BOARD WHEN THE BOARD IS NOT IN SESSION, EXCEPT THAT THE COMMITTEE MAY NOT HAVE THE POWER TO MAKE, AMEND OR REPEAL THE BY-LAWS, NOR TO ELECT MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE CONSISTS OF THE BOARD CHAIR, BOARD VICE-CHAIR, AND CHAIRS FROM THE GOVERNANCE COMMITTEE, DEVELOPMENT COMMITTEE AND FINANCE COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED, SIGNED, AND FILED BY THE PRESIDENT AND CEO. IT IS ALSO REVIEWED BY THE TREASURER PRIOR TO FILING, AND PROVIDED TO THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C EACH SPRING, BOARD MEMBERS ARE ASKED ABOUT POTENTIAL CONFLICTS OF INTEREST. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, THE PERSON INVOLVED MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE BOARD OF DIRECTORS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. THE VOTE(S) OF THE INTERESTED DIRECTOR(S) WILL NOT BE COUNTED. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD CHAIR CONVENES THE EXECUTIVE COMMITTEE ANNUALLY TO REVIEW THE PRESIDENT & CEO'S EMPLOYMENT CONTRACT AND ANNUAL SALARY. A VOTE IS CAPTURED BY EMAIL. COMPENSATION DATA BY ASAE IS REVIEWED TO DETERMINE REASONABLENESS. HIGHEST COMPENSATED EMPLOYEES' SALARY IS DETERMINED BASED ON AN ANNUAL PERFORMANCE REVIEW BY THE PRESIDENT AND CEO. COMPENSATION DATA BY ASAE IS REVIEWED TO DETERMINE COMPARABILITY AND REASONABLENESS. THE MOST RECENT YEAR IN WHICH THE PROCESS INCLUDED REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION WAS 2017. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC ON THEIR WEBSITE OR BY REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS: PROGRAM SERVICE EXPENSES 378,791. MANAGEMENT AND GENERAL EXPENSES 12,258. FUNDRAISING EXPENSES 17,887. TOTAL EXPENSES 408,936. HONORARIA: PROGRAM SERVICE EXPENSES 11,600. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,600. FORM 990, PART IX, LINE 11G, OTHER FEES CONSULTANTS: PROGRAM SERVICES EXPENSES - 378,791 MANAGEMENT AND GENERAL EXPENSES - 12,258 FUNDRAISING - 17,887 TOTAL EXPENSES - 408,936 HONARARIA: PROGRAM SERVICES EXPENSES - 11,600 MANAGEMENT AND GENERAL EXPENSES - 0 FUNDRAISING - 0 TOTAL EXPENSES - 11,600 FORM 990, PART XII, LINE 2C: THE BOARD ASSUMES RESPONSIBILITY FOR TH OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM PRIOR YEARS.